ASSURA PLC - Notifications of transactions by Persons Discharging Managerial Responsibilities (PDMRs)

Notifications of transactions by Persons Discharging Managerial Responsibilities (“PDMRs”)

Assura plc
(Incorporated in England and Wales)
(Company Number: 09349441)
LEI number: 21380026T19N2Y52XF72
LSE Share Code: AGR
JSE Share Code: AHR
ISIN Code: GB00BVGBWW93
("Assura" or the "Company")


Notifications of transactions by Persons Discharging Managerial Responsibilities
("PDMRs")


Assura plc (the "Company"), the UK's leading diversified healthcare REIT, announces the
following transaction in respect of Ordinary Shares of 10 pence each in the Company
("Ordinary Shares"):

   -   Steven Noble, CIO, has acquired 106,319 Ordinary Shares at 36.61p

Following the transactions, the total beneficial interest of Steven Noble and his connected
persons in the Ordinary Shares is 607,630.

The Notification of Dealing Forms can be found below.

This notification is made in accordance with the Market Abuse Regulation.



                                Notification of dealing form

1    Details of the person discharging managerial responsibilities/person
     closely associated

a)   Name              Steven Noble

2    Reason for the notification

a)   Position/status   Chief Investment Officer

b)   Initial           Initial notification
     notification/
     Amendment

3    Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor

a)   Name              Assura plc

b)   LEI               21380026T19N2Y52XF72

4    Details of the transaction(s): section to be repeated for (i) each type
     of instrument; (ii) each type of transaction; (iii) each date; and (iv)
     each place where transactions have been conducted

a)   Description of    Ordinary shares of 10 pence each
     the financial
     instrument,
     type of
     instrument

     Identification    GB00BVGBWW93
     code

b)   Nature of the
     transaction       Acquisition of Ordinary Shares

c)   Price(s) and
     volume(s)         Price(s)          Volume(s)

                       £0.366113 GBP     106,319

d)   Aggregated
     information

      - Aggregated     Aggregate Price   Aggregate       Aggregate Total
        volume                           Volume

      - Price          £0.366113 GBP     106,319         £38,924.77 GBP

e)    Date of the      9 January 2025
      transaction

f)    Place of the     XLON
      transaction

For more information, please contact:

Assura plc                                     Tel: 0161 515 2043
David Purcell, Investor Relations Director     Email: Investor@assura.co.uk

FGS Global                                     Tel: 0207 251 3801
Gordon Simpson                                 Email: Assura@fgsglobal.com

Notes to Editors
Assura plc is the UK's leading diversified healthcare REIT. Assura enables better health
outcomes through its portfolio of more than 600 healthcare buildings, from which over six
million patients are served.
A UK REIT based in Altrincham, Assura is a constituent of the FTSE 250 and the EPRA*
indices. As at 30 September 2024, Assura's portfolio was valued at £3.2 billion and has a
strong track record of growing financial returns and dividends for shareholders.

At Assura, we BUILD for health, having developed over 100 new healthcare buildings in our
history, and at the heart of our strategy sits The Bigger Picture; Healthy Environment (E),
Healthy Communities (S), Healthy Business (G).

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association
Assura plc LEI code: 21380026T19N2Y52XF72

10 January 2025

Corporate Advisor and JSE Sponsor

Nedbank Corporate and Investment Banking, a division of Nedbank Limited

Date: 10-01-2025 01:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.